Skip to content
2000
image of Next-Generation Whole-Exome Pattern: Advanced Methods and Clinical Significance

Abstract

NGS (Next-generation sequencing) has emerged as the primary approach for gene finding in uncommon hereditary disorders. Targeted gene panels, whole genome sequencing (WGS), and whole exome sequencing (WES) are uses of next-generation sequencing and other related technologies. It is possible to explain personal or individual genome sequencing using NGS technology, as well as to detect disease-causing mutations using NGS findings. NGS, deep sequencing or massively parallel are similar words that describe a method of DNA sequencing leading to revolutionary change in genomic research. Due to its cost-effectiveness, Whole-Exome sequencing (WES) using Next-Generation Sequencing (NGS) is becoming increasingly popular in the field of human genetics. As a diagnostic tool, this technology can reduce the duration of the diagnostic process for several patients and has mostly made a significant contribution to the identification of new genes responsible for causing diseases. Considering the diverse range of phenotypic presentations of the diagnosis, NGS has the potential to uncover causative mutations, including de novo, new, and familial variants, related to epileptic syndromes and significantly enhance molecular diagnosis. The present study centres on the potential applications of next-generation exome sequencing in clinical diagnostics and the challenges encountered in the data processing of such data.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cgt/10.2174/0115665232356780250331181436
2025-04-14
2025-09-13

  • From This Site

    /content/journals/cgt/10.2174/0115665232356780250331181436
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Mosele F. Remon J. Mateo J. Westphalen C.B. Barlesi F. Lolkema M.P. Normanno N. Scarpa A. Robson M. Meric-Bernstam F. Wagle N. Stenzinger A. Bonastre J. Bayle A. Michiels S. Bièche I. Rouleau E. Jezdic S. Douillard J-Y. Reis-Filho J.S. Dienstmann R. André F. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. Ann. Oncol. 2020 31 11 1491 1505 10.1016/j.annonc.2020.07.014 32853681
    [Google Scholar]
  2. Zhou X. Ren L. Meng Q. Li Y. Yu Y. Yu J. The next-generation sequencing technology and application. Protein Cell 2010 1 6 520 536 10.1007/s13238‑010‑0065‑3 21204006
    [Google Scholar]
  3. Su Z. Ning B. Fang H. Hong H. Perkins R. Tong W. Shi L. Next-generation sequencing and its applications in molecular diagnostics. Expert Rev. Mol. Diagn. 2011 11 3 333 343 10.1586/erm.11.3 21463242
    [Google Scholar]
  4. Frese K. Katus H. Meder B. Next-generation sequencing: From understanding biology to personalized medicine. Biology (Basel) 2013 2 1 378 398 10.3390/biology2010378 24832667
    [Google Scholar]
  5. Suwinski P. Ong C. Ling M.H.T. Poh Y.M. Khan A.M. Ong H.S. Advancing personalized medicine through the application of whole exome sequencing and big data analytics. Front. Genet. 2019 10 49 10.3389/fgene.2019.00049 30809243
    [Google Scholar]
  6. Wangler M.F. Gonzaga-Jauregui C. Gambin T. Penney S. Moss T. Chopra A. Probst F.J. Xia F. Yang Y. Werlin S. Eglite I. Kornejeva L. Bacino C.A. Baldridge D. Neul J. Lehman E.L. Larson A. Beuten J. Muzny D.M. Jhangiani S. Gibbs R.A. Lupski J.R. Beaudet A. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. PLoS Genet. 2014 10 3 e1004258 10.1371/journal.pgen.1004258 24676022
    [Google Scholar]
  7. Clinical utility of genetic and genomic services: A position statement of the American College of Medical Genetics and Genomics. Genet. Med. 2015 17 6 505 507 10.1038/gim.2015.41 25764213
    [Google Scholar]
  8. Yang Y. Muzny D.M. Xia F. Niu Z. Person R. Ding Y. Ward P. Braxton A. Wang M. Buhay C. Veeraraghavan N. Hawes A. Chiang T. Leduc M. Beuten J. Zhang J. He W. Scull J. Willis A. Landsverk M. Craigen W.J. Bekheirnia M.R. Stray-Pedersen A. Liu P. Wen S. Alcaraz W. Cui H. Walkiewicz M. Reid J. Bainbridge M. Patel A. Boerwinkle E. Beaudet A.L. Lupski J.R. Plon S.E. Gibbs R.A. Eng C.M. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014 312 18 1870 1879 10.1001/jama.2014.14601 25326635
    [Google Scholar]
  9. Li C. Szybowska M. A novel mutation c.4003 G>C in the CREBBP gene in an adult female with Rubinstein–Taybi syndrome presenting with subtle dysmorphic features. Am. J. Med. Genet. A. 2010 152A 11 2939 2941 10.1002/ajmg.a.33693 20949605
    [Google Scholar]
  10. Giampietro P.F. Greenlee R.T. McPherson E. Benetti L.L. Berg R.L. Wagner S.F. Acute health events in adult patients with genetic disorders: The Marshfield Epidemiologic Study Area. Genet. Med. 2006 8 8 474 490 10.1097/01.gim.0000232479.90268.40 16912579
    [Google Scholar]
  11. Shashi V. McConkie-Rosell A. Rosell B. Schoch K. Vellore K. McDonald M. Jiang Y.H. Xie P. Need A. Goldstein D.B. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet. Med. 2014 16 2 176 182 10.1038/gim.2013.99 23928913
    [Google Scholar]
  12. Boycott K.M. Vanstone M.R. Bulman D.E. MacKenzie A.E. Rare-disease genetics in the era of next-generation sequencing: Discovery to translation. Nat. Rev. Genet. 2013 14 10 681 691 10.1038/nrg3555 23999272
    [Google Scholar]
  13. Frésard L. Montgomery S.B. Diagnosing rare diseases after the exome. Molecular Case Studies 2018 4 6 a003392 10.1101/mcs.a003392 30559314
    [Google Scholar]
  14. Kim M.J. Yum M.S. Seo G.H. Lee Y. Jang H.N. Ko T.S. Lee B.H. Clinical application of whole exome sequencing to identify rare but remediable neurologic disorders. J. Clin. Med. 2020 9 11 3724 10.3390/jcm9113724 33233562
    [Google Scholar]
  15. Warr A. Robert C. Hume D. Archibald A. Deeb N. Watson M. Exome sequencing: Current and future perspectives. G3: Genes, Genomes. G3 2015 5 8 1543 1550 10.1534/g3.115.018564 26139844
    [Google Scholar]
  16. Chu Y. Corey D.R. RNA sequencing: Platform selection, experimental design, and data interpretation. Nucleic Acid Ther. 2012 22 4 271 274 10.1089/nat.2012.0367 22830413
    [Google Scholar]
  17. Vanella R. Kovacevic G. Doffini V. Fernández de Santaella J. Nash M.A. High-throughput screening, next generation sequencing and machine learning: Advanced methods in enzyme engineering. Chem. Commun. 2022 58 15 2455 2467 10.1039/D1CC04635G 35107442
    [Google Scholar]
  18. Yang Y. Muzny D.M. Reid J.G. Bainbridge M.N. Willis A. Ward P.A. Braxton A. Beuten J. Xia F. Niu Z. Hardison M. Person R. Bekheirnia M.R. Leduc M.S. Kirby A. Pham P. Scull J. Wang M. Ding Y. Plon S.E. Lupski J.R. Beaudet A.L. Gibbs R.A. Eng C.M. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013 369 16 1502 1511 10.1056/NEJMoa1306555 24088041
    [Google Scholar]
  19. Nigro V. Savarese M. Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders. Curr. Opin. Neurol. 2016 29 5 621 627 10.1097/WCO.0000000000000371 27454578
    [Google Scholar]
  20. Abolhassani A. Fattahi Z. Beheshtian M. Fadaee M. Vazehan R. Ahangari F. Dehdahsi S. Zonooz F.M. Parsimehr E. Kalhor Z. Peymani F. Nouri M.M. Babanejad M. Noudehi K. Fatehi F. Najafabadi Z.S. Afroozan F. Yazdan H. Bozorgmehr B. Azarkeivan A. Mahdavi S.S. Nikuei P. Fatehi F. Jamali P. Ashrafi M.R. Karimzadeh P. Habibi H. Kahrizi K. Nafissi S. Kariminejad A. Najmabadi H. Clinical application of next generation sequencing for mendelian disease diagnosis in the iranian population. NPJ Genom. Med. 2024 9 1 12 10.1038/s41525‑024‑00393‑0 38374194
    [Google Scholar]
  21. Rodino K.G. Simner P.J. Status check: Next-generation sequencing for infectious-disease diagnostics. J. Clin. Invest. 2024 134 4 e178003 10.1172/JCI178003 38357923
    [Google Scholar]
  22. Choon Y.W. Choon Y.F. Nasarudin N.A. Jasmi A.F. Remli M.A. Alkayali M.H. Mohamad M.S. Artificial intelligence and database for NGS-based diagnosis in rare disease. Front. Genet. 2024 14 1258083 10.3389/fgene.2023.1258083 38371307
    [Google Scholar]
  23. Biesecker L.G. Green R.C. Diagnostic clinical genome and exome sequencing. N. Engl. J. Med. 2014 370 25 2418 2425 10.1056/NEJMra1312543 24941179
    [Google Scholar]
  24. AK Eurordis A.K. Faurisson F. The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and care in Europe. Europe EURORDIS-Rare Diseases 2009
    [Google Scholar]
  25. Ligt D.J. Willemsen M.H. Bon V.B.W.M. Kleefstra T. Yntema H.G. Kroes T. Silfhout V.V.A.T. Koolen D.A. Vries D.P. Gilissen C. Rosario D.M. Hoischen A. Scheffer H. Vries D.B.B.A. Brunner H.G. Veltman J.A. Vissers L.E.L.M. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 2012 367 20 1921 1929 10.1056/NEJMoa1206524 23033978
    [Google Scholar]
  26. Tang B.S. Attention should be drawn to rare diseases and interpretation of sequence variants. Chin. Med. J. 2016 129 9 1009 1010 10.4103/0366‑6999.180531 27098782
    [Google Scholar]
  27. Willemsen M.H. Kleefstra T. Making headway with genetic diagnostics of intellectual disabilities. Clin. Genet. 2014 85 2 101 110 10.1111/cge.12244 23895455
    [Google Scholar]
  28. Lancaster E.M. Jablons D. Kratz J.R. Applications of next-generation sequencing in neoantigen prediction and cancer vaccine development. Genet. Test. Mol. Biomarkers 2020 24 2 59 66 10.1089/gtmb.2018.0211 30907630
    [Google Scholar]
  29. Hennekam R.C.M. Biesecker L.G. Next-generation sequencing demands next-generation phenotyping. Hum. Mutat. 2012 33 5 884 886 10.1002/humu.22048 22457028
    [Google Scholar]
  30. Rosenfeld J.A. Mason C.E. Smith T.M. Limitations of the human reference genome for personalized genomics. PLoS One 2012 7 7 e40294 10.1371/journal.pone.0040294 22811759
    [Google Scholar]
  31. Verma A. Next-generation sequencing and genetic diagnosis of Charcot-Marie-Tooth disease. Ann. Indian Acad. Neurol. 2014 17 4 383 386 10.4103/0972‑2327.144004 25506157
    [Google Scholar]
  32. Kadalayil L. Rafiq S. Rose-Zerilli M.J.J. Pengelly R.J. Parker H. Oscier D. Strefford J.C. Tapper W.J. Gibson J. Ennis S. Collins A. Exome sequence read depth methods for identifying copy number changes. Brief. Bioinform. 2015 16 3 380 392 10.1093/bib/bbu027 25169955
    [Google Scholar]
  33. Abecasis G.R. Auton A. Brooks L.D. DePristo M.A. Durbin R.M. Handsaker R.E. Kang H.M. Marth G.T. McVean G.A. An integrated map of genetic variation from 1,092 human genomes. Nature 2012 491 7422 56 65 10.1038/nature11632 23128226
    [Google Scholar]
  34. O’Rawe J. Jiang T. Sun G. Wu Y. Wang W. Hu J. Bodily P. Tian L. Hakonarson H. Johnson W.E. Wei Z. Wang K. Lyon G.J. Low concordance of multiple variant-calling pipelines: Practical implications for exome and genome sequencing. Genome Med. 2013 5 3 28 10.1186/gm432 23537139
    [Google Scholar]
  35. Thorvaldsdóttir H. Robinson J.T. Mesirov J.P. Integrative Genomics Viewer (IGV): High-performance genomics data visualization and exploration. Brief. Bioinform. 2013 14 2 178 192 10.1093/bib/bbs017 22517427
    [Google Scholar]
  36. Yu H. Mehta A. Wang G. Hauswirth W.W. Chiodo V. Boye S.L. Guy J. Next-generation sequencing of mitochondrial targeted AAV transfer of human ND4 in mice. Mol. Vis. 2013 19 1482 1491 23869167
    [Google Scholar]
  37. Tulchin N. Ornstein L. Dikman S. Strauchen J. Jaffer S. Nagi C. Bleiweiss I. Kornreich R. Edelmann L. Brown K. Bodian C. Nair V.D. Chambon M. Woods N.T. Monteiro A.N.A. Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell Int. 2013 13 1 70 10.1186/1475‑2867‑13‑70 23855721
    [Google Scholar]
  38. Fu W. O’Connor T.D. Jun G. Kang H.M. Abecasis G. Leal S.M. Gabriel S. Rieder M.J. Altshuler D. Shendure J. Nickerson D.A. Bamshad M.J. Akey J.M. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013 493 7431 216 220 10.1038/nature11690 23201682
    [Google Scholar]
  39. Bavarva J.H. Tae H. Settlage R.E. Garner H.R. Characterizing the genetic basis for nicotine induced cancer development: A transcriptome sequencing study. PLoS One 2013 8 6 e67252 10.1371/journal.pone.0067252 23825647
    [Google Scholar]
  40. Boria I. Boatti L. Pesole G. Mignone F. NGS-trex: Next generation sequencing transcriptome profile explorer. BMC Bioinformatics 2013 14 S7 Suppl. 7 S10 10.1186/1471‑2105‑14‑S7‑S10 23815181
    [Google Scholar]
  41. Barnes D.M. Legal limbo for ecstasy. Science 1988 239 4842 865 10.1126/science.2893453 2893453
    [Google Scholar]
  42. Farwell K.D. Shahmirzadi L. El-Khechen D. Powis Z. Chao E.C. Davis T.B. Baxter R.M. Zeng W. Mroske C. Parra M.C. Gandomi S.K. Lu I. Li X. Lu H. Lu H.M. Salvador D. Ruble D. Lao M. Fischbach S. Wen J. Lee S. Elliott A. Dunlop C.L.M. Tang S. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: Results from 500 unselected families with undiagnosed genetic conditions. Genet. Med. 2015 17 7 578 586 10.1038/gim.2014.154 25356970
    [Google Scholar]
  43. Carroll C.J. Brilhante V. Suomalainen A. Next-generation sequencing for mitochondrial disorders. Br. J. Pharmacol. 2014 171 8 1837 1853 10.1111/bph.12469 24138576
    [Google Scholar]
  44. Valencia C.A. Husami A. Holle J. Johnson J.A. Qian Y. Mathur A. Wei C. Indugula S.R. Zou F. Meng H. Wang L. Li X. Fisher R. Tan T. Begtrup H.A. Collins K. Wusik K.A. Neilson D. Burrow T. Schorry E. Hopkin R. Keddache M. Harley J.B. Kaufman K.M. Zhang K. Clinical impact and cost-effectiveness of whole exome sequencing as a diagnostic tool: A pediatric center’s experience. Front Pediatr. 2015 3 67 10.3389/fped.2015.00067 26284228
    [Google Scholar]
  45. Hu X. Li N. Xu Y. Li G. Yu T. Yao R. Fu L. Wang J. Yin L. Yin Y. Wang Y. Jin X. Wang X. Wang J. Shen Y. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: The China experience. Genet. Med. 2018 20 9 1045 1053 10.1038/gim.2017.195 29095814
    [Google Scholar]
  46. Meng L. Pammi M. Saronwala A. Magoulas P. Ghazi A.R. Vetrini F. Zhang J. He W. Dharmadhikari A.V. Qu C. Ward P. Braxton A. Narayanan S. Ge X. Tokita M.J. Santiago-Sim T. Dai H. Chiang T. Smith H. Azamian M.S. Robak L. Bostwick B.L. Schaaf C.P. Potocki L. Scaglia F. Bacino C.A. Hanchard N.A. Wangler M.F. Scott D. Brown C. Hu J. Belmont J.W. Burrage L.C. Graham B.H. Sutton V.R. Craigen W.J. Plon S.E. Lupski J.R. Beaudet A.L. Gibbs R.A. Muzny D.M. Miller M.J. Wang X. Leduc M.S. Xiao R. Liu P. Shaw C. Walkiewicz M. Bi W. Xia F. Lee B. Eng C.M. Yang Y. Lalani S.R. Use of exome sequencing for infants in intensive care units: Ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr. 2017 171 12 e173438 10.1001/jamapediatrics.2017.3438 28973083
    [Google Scholar]
  47. Sagi-Dain L. Shemer L. Zelnik N. Zoabi Y. Orit S. Adir V. Schif A. Peleg A. Whole-exome sequencing reveals a novel missense mutation in the MARS gene related to a rare Charcot-Marie-Tooth neuropathy type 2U. J. Peripher. Nerv. Syst. 2018 23 2 138 142 10.1111/jns.12264 29582526
    [Google Scholar]
  48. Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Wang B. Xiang H. Cheng Z. Xiong Y. Zhao Y. Li Y. Wang X. Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020 323 11 1061 1069 10.1001/jama.2020.1585 32031570
    [Google Scholar]
  49. Sadhwani A. Sanjana N.E. Willen J.M. Calculator S.N. Black E.D. Bean L.J.H. Li H. Tan W.H. Two Angelman families with unusually advanced neurodevelopment carry a start codon variant in the most highly expressed UBE3A isoform. Am. J. Med. Genet. A. 2018 176 7 1641 1647 10.1002/ajmg.a.38831 29737008
    [Google Scholar]
  50. Lionel A.C. Costain G. Monfared N. Walker S. Reuter M.S. Hosseini S.M. Thiruvahindrapuram B. Merico D. Jobling R. Nalpathamkalam T. Pellecchia G. Sung W.W.L. Wang Z. Bikangaga P. Boelman C. Carter M.T. Cordeiro D. Cytrynbaum C. Dell S.D. Dhir P. Dowling J.J. Heon E. Hewson S. Hiraki L. Inbar-Feigenberg M. Klatt R. Kronick J. Laxer R.M. Licht C. MacDonald H. Mercimek-Andrews S. Mendoza-Londono R. Piscione T. Schneider R. Schulze A. Silverman E. Siriwardena K. Snead O.C. Sondheimer N. Sutherland J. Vincent A. Wasserman J.D. Weksberg R. Shuman C. Carew C. Szego M.J. Hayeems R.Z. Basran R. Stavropoulos D.J. Ray P.N. Bowdin S. Meyn M.S. Cohn R.D. Scherer S.W. Marshall C.R. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. 2018 20 4 435 443 10.1038/gim.2017.119 28771251
    [Google Scholar]
  51. Vissers L.E.L.M. Nimwegen V.K.J.M. Schieving J.H. Kamsteeg E.J. Kleefstra T. Yntema H.G. Pfundt R. Wilt D.V.G.J. Krabbenborg L. Brunner H.G. Burg D.V.S. Grutters J. Veltman J.A. Willemsen M.A.A.P. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet. Med. 2017 19 9 1055 1063 10.1038/gim.2017.1 28333917
    [Google Scholar]
  52. Bertier G. Hétu M. Joly Y. Unsolved challenges of clinical whole-exome sequencing: A systematic literature review of end-users’ views. BMC Med. Genom. 2016 9 1 52 10.1186/s12920‑016‑0213‑6 27514372
    [Google Scholar]
  53. Seshadri R. Leahy S.C. Attwood G.T. Teh K.H. Lambie S.C. Cookson A.L. Eloe-Fadrosh E.A. Pavlopoulos G.A. Hadjithomas M. Varghese N.J. Paez-Espino D. Perry R. Henderson G. Creevey C.J. Terrapon N. Lapebie P. Drula E. Lombard V. Rubin E. Kyrpides N.C. Henrissat B. Woyke T. Ivanova N.N. Kelly W.J. Cultivation and sequencing of rumen microbiome members from the Hungate1000 Collection. Nat. Biotechnol. 2018 36 4 359 367 10.1038/nbt.4110 29553575
    [Google Scholar]
  54. Lazaridis KN Schahl KA Cousin MA Babovic-Vuksanovic D Riegert-Johnson DL Gavrilova RH McAllister TM Lindor NM Abraham RS Ackerman MJ Pichurin PN Outcome of whole exome sequencing for diagnostic odyssey cases of an individualized medicine clinic: The Mayo Clinic experience. Mayo. Clin. Proc. 2016 91 3 297 307 10.1016/j.mayocp.2015.12.018
    [Google Scholar]
  55. Deverka P.A. Kaufman D. McGuire A.L. Overcoming the reimbursement barriers for clinical sequencing. JAMA 2014 312 18 1857 1858 10.1001/jama.2014.14915 25387182
    [Google Scholar]
  56. Skladal D. Halliday J. Thorburn D.R. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003 126 8 1905 1912 10.1093/brain/awg170 12805096
    [Google Scholar]
  57. Pagniez-Mammeri H. Rak M. Legrand A. Bénit P. Rustin P. Slama A. Mitochondrial complex I deficiency of nuclear origin. Mol. Genet. Metab. 2012 105 2 173 179 10.1016/j.ymgme.2011.10.001 22099533
    [Google Scholar]
  58. Munnich A. Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am. J. Med. Genet. 2001 106 1 4 17 10.1002/ajmg.1391 11579420
    [Google Scholar]
  59. Haack T.B. Madignier F. Herzer M. Lamantea E. Danhauser K. Invernizzi F. Koch J. Freitag M. Drost R. Hillier I. Haberberger B. Mayr J.A. Ahting U. Tiranti V. Rötig A. Iuso A. Horvath R. Tesarova M. Baric I. Uziel G. Rolinski B. Sperl W. Meitinger T. Zeviani M. Freisinger P. Prokisch H. Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9. J. Med. Genet. 2012 49 2 83 89 10.1136/jmedgenet‑2011‑100577 22200994
    [Google Scholar]
  60. Zhou Q. Huang H. Ma L. Zhu T. The application of next-generation sequencing (NGS) in neonatal-onset urea cycle disorders (UCDs): Clinical course, metabolomic profiling, and genetic findings in nine Chinese hyperammonemia patients. BioMed Res. Int. 2020 2020 1 5690915 10.1155/2020/5690915 32934962
    [Google Scholar]
  61. Holley R.W. Apgar J. Everett G.A. Madison J.T. Marquisee M. Merrill S.H. Penswick J.R. Zamir A. Structure of a ribonucleic acid. Science 1965 147 3664 1462 1465 10.1126/science.147.3664.1462 14263761
    [Google Scholar]
  62. Heather J.M. Chain B. The sequence of sequencers: The history of sequencing DNA. Genomics 2016 107 1 1 8 10.1016/j.ygeno.2015.11.003 26554401
    [Google Scholar]
  63. Sanger F. Nicklen S. Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977 74 12 5463 5467 10.1073/pnas.74.12.5463 271968
    [Google Scholar]
  64. Barba M. Czosnek H. Hadidi A. Historical perspective, development and applications of next-generation sequencing in plant virology. Viruses 2014 6 1 106 136 10.3390/v6010106 24399207
    [Google Scholar]
  65. Pervez M.T. Hasnain M.J. Abbas S.H. Moustafa M.F. Aslam N. Shah S.S.M. A comprehensive review of performance of next-generation sequencing platforms. BioMed Res. Int. 2022 2022 1 3457806 10.1155/2022/3457806 36212714
    [Google Scholar]
  66. Schuster S.C. Next-generation sequencing transforms today’s biology. Nat. Methods 2008 5 1 16 18 10.1038/nmeth1156 18165802
    [Google Scholar]
  67. Costain G. Cohn R.D. Scherer S.W. Marshall C.R. Genome sequencing as a diagnostic test. CMAJ 2021 193 42 E1626 E1629 10.1503/cmaj.210549 34697096
    [Google Scholar]
  68. Brlek P. Bulić L. Bračić M. Projić P. Škaro V. Shah N. Shah P. Primorac D. implementing whole genome sequencing (WGS) in clinical practice: Advantages, challenges, and future perspectives. Cells 2024 13 6 504 10.3390/cells13060504 38534348
    [Google Scholar]
  69. Rabbani B. Tekin M. Mahdieh N. The promise of whole-exome sequencing in medical genetics. J. Hum. Genet. 2014 59 1 5 15 10.1038/jhg.2013.114 24196381
    [Google Scholar]
  70. Dijk V.E.L. Auger H. Jaszczyszyn Y. Thermes C. Ten years of next-generation sequencing technology. Trends Genet. 2014 30 9 418 426 10.1016/j.tig.2014.07.001 25108476
    [Google Scholar]
  71. Williams M.J. Sottoriva A. Graham T.A. Measuring clonal evolution in cancer with genomics. Annu. Rev. Genomics Hum. Genet. 2019 20 1 309 329 10.1146/annurev‑genom‑083117‑021712 31059289
    [Google Scholar]
  72. Wang J. Tian T. Li X. Zhang Y. Noncoding RNAs emerging as drugs or drug targets: Their chemical modification, bio-conjugation and intracellular regulation. Molecules 2022 27 19 6717 10.3390/molecules27196717 36235253
    [Google Scholar]
  73. Handy D.E. Castro R. Loscalzo J. Epigenetic modifications. Circulation 2011 123 19 2145 2156 10.1161/CIRCULATIONAHA.110.956839 21576679
    [Google Scholar]
  74. Fuso A. Aging and Disease: The epigenetic bridge. Epigenet. Human Dis. 2024 6 935 973 10.1016/B978‑0‑12‑812215‑0.00031‑5
    [Google Scholar]
  75. Heyn H. Esteller M. DNA methylation profiling in the clinic: Applications and challenges. Nat. Rev. Genet. 2012 13 10 679 692 10.1038/nrg3270 22945394
    [Google Scholar]
  76. Zhu H. Zhu H. Tian M. Wang D. He J. Xu T. DNA methylation and hydroxymethylation in cervical cancer: Diagnosis, prognosis and treatment. Front. Genet. 2020 11 347 10.3389/fgene.2020.00347 32328088
    [Google Scholar]
  77. Thomas T. Gilbert J. Meyer F. Metagenomics - a guide from sampling to data analysis. Microb. Inform. Exp. 2012 2 1 3 10.1186/2042‑5783‑2‑3 22587947
    [Google Scholar]
  78. Bellemain E. Carlsen T. Brochmann C. Coissac E. Taberlet P. Kauserud H. ITS as an environmental DNA barcode for fungi: An in silico approach reveals potential PCR biases. BMC Microbiol. 2010 10 1 189 10.1186/1471‑2180‑10‑189 20618939
    [Google Scholar]
  79. Erman B. Aba U. Ipsir C. Pehlivan D. Aytekin C. Cildir G. Cicek B. Bozkurt C. Tekeoglu S. Kaya M. Aydogmus C. Cipe F. Sucak G. Eltan S.B. Ozen A. Barıs S. Karakoc-Aydiner E. Kıykım A. Karaatmaca B. Kose H. Uygun D.F.K. Celmeli F. Arikoglu T. Ozcan D. Keskin O. Arık E. Aytekin E.S. Cesur M. Kucukosmanoglu E. Kılıc M. Yuksek M. Bıcakcı Z. Esenboga S. Ayvaz D.Ç. Sefer A.P. Guner S.N. Keles S. Reisli I. Musabak U. Demirbas N.D. Haskologlu S. Kilic S.S. Metin A. Dogu F. Ikinciogulları A. Tezcan I. Genetic evaluation of the patients with clinically diagnosed inborn errors of immunity by whole exome sequencing: Results from a specialized research center for immunodeficiency in Türkiye. J. Clin. Immunol. 2024 44 7 157 10.1007/s10875‑024‑01759‑w 38954121
    [Google Scholar]
  80. Kanzi A.M. San J.E. Chimukangara B. Wilkinson E. Fish M. Ramsuran V. Oliveira D.T. Next generation sequencing and bioinformatics analysis of family genetic inheritance. Front. Genet. 2020 11 544162 10.3389/fgene.2020.544162 33193618
    [Google Scholar]
  81. Satam H. Joshi K. Mangrolia U. Waghoo S. Zaidi G. Rawool S. Thakare R.P. Banday S. Mishra A.K. Das G. Malonia S.K. Next-generation sequencing technology: Current trends and advancements. Biology 2023 12 7 997 10.3390/biology12070997 37508427
    [Google Scholar]
  82. Samarasam I. Esophageal cancer in India: Current status and future perspectives. Inter. J. Adv. Med. Health Res. 2017 4 1 5 10.4103/IJAMR.IJAMR_19_17
    [Google Scholar]
  83. Mardis E.R. Wilson R.K. Cancer genome sequencing: A review. Hum. Mol. Genet. 2009 18 R2 R163 R168 10.1093/hmg/ddp396 19808792
    [Google Scholar]
  84. Nowell P.C. Hungerford D.A. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 1960 25 1 85 109 14427847
    [Google Scholar]
  85. Wang L. Wheeler D.A. Genomic sequencing for cancer diagnosis and therapy. Annu. Rev. Med. 2014 65 1 33 48 10.1146/annurev‑med‑120811‑171056 24274147
    [Google Scholar]
  86. Schwartzentruber J. Korshunov A. Liu X.Y. Jones D.T.W. Pfaff E. Jacob K. Sturm D. Fontebasso A.M. Quang D.A.K. Tönjes M. Hovestadt V. Albrecht S. Kool M. Nantel A. Konermann C. Lindroth A. Jäger N. Rausch T. Ryzhova M. Korbel J.O. Hielscher T. Hauser P. Garami M. Klekner A. Bognar L. Ebinger M. Schuhmann M.U. Scheurlen W. Pekrun A. Frühwald M.C. Roggendorf W. Kramm C. Dürken M. Atkinson J. Lepage P. Montpetit A. Zakrzewska M. Zakrzewski K. Liberski P.P. Dong Z. Siegel P. Kulozik A.E. Zapatka M. Guha A. Malkin D. Felsberg J. Reifenberger G. Deimling V.A. Ichimura K. Collins V.P. Witt H. Milde T. Witt O. Zhang C. Castelo-Branco P. Lichter P. Faury D. Tabori U. Plass C. Majewski J. Pfister S.M. Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012 482 7384 226 231 10.1038/nature10833 22286061
    [Google Scholar]
  87. Yan X.J. Xu J. Gu Z.H. Pan C.M. Lu G. Shen Y. Shi J.Y. Zhu Y.M. Tang L. Zhang X.W. Liang W.X. Mi J.Q. Song H.D. Li K.Q. Chen Z. Chen S.J. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat. Genet. 2011 43 4 309 315 10.1038/ng.788 21399634
    [Google Scholar]
  88. Jiang T. Tan M.S. Tan L. Yu J.T. Application of next-generation sequencing technologies in Neurology. Ann. Transl. Med. 2014 2 12 125 25568878
    [Google Scholar]
  89. Srivastava S. Cohen J.S. Vernon H. Barañano K. McClellan R. Jamal L. Naidu S. Fatemi A. Clinical whole exome sequencing in child neurology practice. Ann. Neurol. 2014 76 4 473 483 10.1002/ana.24251 25131622
    [Google Scholar]
  90. Reuter C.M. Kohler J.N. Bonner D. Zastrow D. Fernandez L. Dries A. Marwaha S. Davidson J. Brokamp E. Herzog M. Hong J. Macnamara E. Rosenfeld J.A. Schoch K. Spillmann R. Loscalzo J. Krier J. Stoler J. Sweetser D. Palmer C.G.S. Phillips J.A. Shashi V. Adams D.A. Yang Y. Ashley E.A. Fisher P.G. Mulvihill J.J. Bernstein J.A. Wheeler M.T. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing. J. Genet. Couns. 2019 28 6 1107 1118 10.1002/jgc4.1161 31478310
    [Google Scholar]
  91. Ligt D.J. Boone P.M. Pfundt R. Vissers L.E.L.M. Richmond T. Geoghegan J. O’Moore K. Leeuw D.N. Shaw C. Brunner H.G. Lupski J.R. Veltman J.A. Hehir-Kwa J.Y. Detection of clinically relevant copy number variants with whole-exome sequencing. Hum. Mutat. 2013 34 10 1439 1448 10.1002/humu.22387 23893877
    [Google Scholar]
  92. Genovese G. Kähler A.K. Handsaker R.E. Lindberg J. Rose S.A. Bakhoum S.F. Chambert K. Mick E. Neale B.M. Fromer M. Purcell S.M. Svantesson O. Landén M. Höglund M. Lehmann S. Gabriel S.B. Moran J.L. Lander E.S. Sullivan P.F. Sklar P. Grönberg H. Hultman C.M. McCarroll S.A. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 2014 371 26 2477 2487 10.1056/NEJMoa1409405 25426838
    [Google Scholar]
  93. Alkodsi A. Louhimo R. Hautaniemi S. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data. Brief. Bioinform. 2015 16 2 242 254 10.1093/bib/bbu004 24599115
    [Google Scholar]
  94. Zelst-Stams V.W.A. Scheffer H. Veltman J.A. Clinical exome sequencing in daily practice: 1,000 patients and beyond. Genome Med. 2014 6 1 2 10.1186/gm521 24456652
    [Google Scholar]
  95. Thiffault I. Farrow E. Zellmer L. Berrios C. Miller N. Gibson M. Caylor R. Jenkins J. Faller D. Soden S. Saunders C. Clinical genome sequencing in an unbiased pediatric cohort. Genet. Med. 2019 21 2 303 310 10.1038/s41436‑018‑0075‑8 30008475
    [Google Scholar]
  96. Grosse S.D. Farnaes L. Genomic sequencing in acutely ill infants: What will it take to demonstrate clinical value? Genet. Med. 2019 21 2 269 271 10.1038/s41436‑018‑0124‑3 30100610
    [Google Scholar]
  97. French C.E. Delon I. Dolling H. Sanchis-Juan A. Shamardina O. Mégy K. Abbs S. Austin T. Bowdin S. Branco R.G. Firth H. Rowitch D.H. Raymond F.L. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019 45 5 627 636 10.1007/s00134‑019‑05552‑x 30847515
    [Google Scholar]
  98. Kingsmore S.F. Henderson A. Owen M.J. Clark M.M. Hansen C. Dimmock D. Chambers C.D. Jeliffe-Pawlowski L.L. Hobbs C. Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing. NPJ Genom. Med. 2020 5 1 49 10.1038/s41525‑020‑00155‑8 33154820
    [Google Scholar]
  99. Nayarisseri A. Yadav M. Bhatia M. Pandey A. Elkunchwar A. Paul N. Sharma D. Kumar G. Impact of Next-Generation Whole-Exome sequencing in molecular diagnostics. Drug Invent. Today 2013 5 4 327 334 10.1016/j.dit.2013.07.005
    [Google Scholar]
  100. Chandra P. Rastogi V. Porwal M. Sharma H. Verma A. Sachan N. A critical review on lipid nanoparticle-based siRNA formulations for breast cancer management. Pharm. Nanotechnol. 2024 13 1 19 10.2174/0122117385330006241120084721 39670497
    [Google Scholar]
  101. Kumari A. Bajwa N. Tamana Ashique S. Sharma H. Mishra N. Rathore C. Singh P.A. From lab bench to bedside: Advancing malaria treatments through research, patents, and clinical trials. Curr. Treat. Options Infect. Dis. 2024 17 1 4 10.1007/s40506‑024‑00279‑w
    [Google Scholar]
  102. Noman A.A. Sharma D.P. Mim J.T. Azad A.M. Sharma H. Molecular docking and ADMET analysis of coenzyme Q10 as a potential therapeutic agent for Alzheimer’s disease. Aging Pathobiol. Ther. 2024 6 4 1 13 10.31491/APT.2024.12.155
    [Google Scholar]
  103. Inamdar A. Gurupadayya B. Halagali P. Tippavajhala V.K. Khan F. Pathak R. Sharma H. Unraveling neurological drug delivery: Polymeric nanocarriers for enhanced blood-brain barrier penetration. Curr. Drug Targets 2024 26 1 24 10.2174/0113894501339455241101065040 39513304
    [Google Scholar]
  104. Mishra R. Kaur V. Nogai L. Bhandari M. Bajaj M. Pathak R. Lohia R. Saxena A. Sharma H. Emerging insights and novel therapeutics in polycystic ovary syndrome. Biochem. Cell. Arch. 2024 24 2 1613 1626 10.51470/bca.2024.24.2.1613
    [Google Scholar]
  105. Inamdar A. Gurupadayya B. Halagali P. S N. Pathak R. Singh H. Sharma H. Cutting-edge strategies for overcoming therapeutic barriers in alzheimer’s disease. Curr. Pharm. Des. 2024 1 21 10.2174/0113816128344571241018154506 39492772
    [Google Scholar]
  106. Noman A.A. Afrosa H. Lihu I.K. Sarkar O. Nabin N.R. Datta M. Pathak R. Sharma H. Vitamin D and neurological health: Unraveling risk factors, disease progression, and treatment potential. CNS Neurol. Disord. Drug Targets 2024 24 1 12 10.2174/0118715273330972241009092828 39440730
    [Google Scholar]
  107. Chandra P. Porwal M. Rastogi V. Tyagi S.J. Sharma H. Verma A. Carb-loaded passion: A comprehensive exploration of carbohydrates in shaping aphrodisiac effects. Macromol. Symp. 2024 413 5 2400064 10.1002/masy.202400064
    [Google Scholar]
  108. Sarkar S. Bhui U. Kumar B. Ashique S. Kumar P. Sharma H. Bhowmick M. Pal R. Kumar T. Correlation between cognitive impairment and peripheral biomarkers - significance of phosphorylated tau and amyloid-β in alzheimer’s disease: A new insight. Curr. Psychiatry Res. Rev. 2024 21 1 25 10.2174/0126660822329981241007105405
    [Google Scholar]
  109. Pathak R. Sharma H. Chandra P. Halagali P. Ali Z. A compressive review: Mechanisms underlying the use of diuretics in the treatment of hypertension. Indian J Nat Sci. 2024 15 85 78063 78075
    [Google Scholar]
  110. Sharma H. Chandra P. Pathak R. Bhandari M. Arushi S.V. Advancements in the therapeutic approaches to treat neurological disorders. Cah Magellanes-NS. 2024 6 2 4328 4389
    [Google Scholar]
  111. Chandra P. Sharma H. Phosphodiesterase inhibitors for treatment of Alzheimer’s Disease. INDIAN DRUGS 2024 61 7 7 22 10.53879/id.61.07.14382
    [Google Scholar]
  112. Pathak R. Sharma S. Bhandari M. Nogai L. Mishra R. Saxena A. Km R.S.H. Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: Causes, consequences and interventions. J. Exp. Zool. India 2024 21 2 2447 2461 10.59467/jez.2024.27.2.2447
    [Google Scholar]
  113. Singh A. Kumar P. Sharma H. Breakthrough opportunities of nanotheranostics in psoriasis: From pathogenesis to management strategy. Infect. Disord. Drug Targets 2024 24 1 20 10.2174/0118715265298802240603120251 39075964
    [Google Scholar]
  114. Sharma H. Tyagi S.J. Varshney P. Pathak N. Pathak R. A review on mpox: Diagnosis, prevention and treatments. Coronaviruses 2024 5 1 17 10.2174/0126667975301557240604113752
    [Google Scholar]
  115. Sharma H. Halagali P. Majumder A. Sharma V. Pathak R. Natural compounds targeting signaling pathways in breast cancer therapy. African J. Biol. Sci. 2024 6 10 5430 5479 10.33472/AFJBS.6.10.2024.5430‑5479
    [Google Scholar]
  116. Sharma H. Pathak R. Biswas D. Unveiling the therapeutic potential of modern probiotics in addressing neurodegenerative disorders: A comprehensive exploration, review and future perspectives on intervention strategies. Curr. Psychiatry Res. Rev. 2024 20 1 25 10.2174/0126660822304321240520075036
    [Google Scholar]
  117. Pathak R. Kaur V. Sharma S. Bhandari M. Mishra R. Saxena A. Pazopanib: Effective monotherapy for precise cancer treatment, targeting specific mutations and tumors. Afr.J.Bio.Sc. 2024 6 9 1311 1330 10.33472/AFJBS.6.9.2024.1311‑1330
    [Google Scholar]
  118. Kapoor D.U. Sharma H. Maheshwari R. Pareek A. Gaur M. Prajapati B.G. Castro G.R. Thanawuth K. Suttiruengwong S. Sriamornsak P. Konjac glucomannan: A comprehensive review of its extraction, health benefits, and pharmaceutical applications. Carbohydr. Polym. 2024 339 122266 10.1016/j.carbpol.2024.122266 38823930
    [Google Scholar]
  119. Chandra P. Ali Z. Fatima N. Sharma H. Sachan N. Sharma K.K. Shankhpushpi (Convolvulus pluricaulis): Exploring its cognitive enhancing mechanisms and therapeutic potential in neurodegenerative disorders. Curr. Bioact. Compd. 2024 20 2 1 9 10.2174/0115734072292339240416095600
    [Google Scholar]
  120. Kumar P. Sharma H. Singh A. Durgapal S. Kukreti G. Bhowmick M. Bhowmick P. Ashique S. Targeting the interplay of proteins through PROTACS for management cancer and associated disorders. Curr. Cancer Ther. Rev. 2024 20 1 6 10.2174/0115733947304806240417092449
    [Google Scholar]
  121. Sharma H. Chandra P. Effects of natural remedies on memory loss and Alzheimer’s disease. Afr.J.Bio.Sc. 2024 6 7 187 211 10.33472/AFJBS.6.7.2024.187‑211
    [Google Scholar]
  122. Halagali P. Inamdar A. Singh J. Anand A. Sadhu P. Pathak R. Sharma H. Biswas D. Phytochemicals, herbal extracts, and dietary supplements for metabolic disease management. Endocr. Metab. Immune Disord. Drug Targets 2024 24 1 9 10.2174/0118715303287911240409055710 38676520
    [Google Scholar]
  123. Das S. Mukherjee T. Mohanty S. Nayak N. Mal P. Ashique S. Pal R. Mohanto S. Sharma H. Impact of NF-κB signaling and sirtuin-1 protein for targeted inflammatory intervention. Curr. Pharm. Biotechnol. 2024 25 1 9 10.2174/0113892010301469240409082212 38638042
    [Google Scholar]
  124. Sharma H. Kaushik M. Goswami P. Sreevani S. Chakraborty A. Ashique S. Pal R. Role of miRNAs in brain development. MicroRNA 2024 13 2 96 109 10.2174/0122115366287127240322054519 38571343
    [Google Scholar]
  125. Ashique S. Bhowmick M. Pal R. Khatoon H. Kumar P. Sharma H. Garg A. Kumar S. Das U. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success. Adv. Cancer Biol. Metastasis 2024 10 100114 10.1016/j.adcanc.2024.100114
    [Google Scholar]
  126. Ashique S. Pal R. Sharma H. Mishra N. Garg A. Unraveling the emerging niche role of extracellular vesicles (Evs) in traumatic brain injury (TBI). CNS Neurol. Disord. Drug Targets 2024 23 11 1357 1370 10.2174/0118715273288155240201065041 38351688
    [Google Scholar]
  127. Kumar P. Pandey S. Ahmad F. Verma A. Sharma H. Ashique S. Carbon nanotubes: A targeted drug delivery against cancer cell. Curr. Nanosci. 2023 9 1 31 10.2174/0115734137271865231105070727
    [Google Scholar]
  128. Sharma H Chandra P Verma A Pandey SN Kumar P Sigh A Therapeutic approaches of nutraceuticals in the prevention of neurological disorders. Eur. Chem. Bull. 2023 12 5 1575 1596 10.48047/ecb/2023.12.si5a.038
    [Google Scholar]
  129. Sharma H. Chandra P. Challenges and future prospects: A benefaction of phytoconstituents on molecular targets pertaining to alzheimer’s disease. Int. J. Pharm. Investig. 2023 14 1 117 126 10.5530/ijpi.14.1.15
    [Google Scholar]
  130. Sharma H. Pathak R. Jain S. Bhandari M. Mishra R. Reena K. Varshney P. Ficus racemosa L: A review on its important medicinal uses, phytochemicals and biological activities. J. Popul. Ther. Clin. Pharmacol. 2023 30 17 213 227 10.47750/jptcp.2023.30.17.018
    [Google Scholar]
  131. Singh L.P. Gugulothu S. Perusomula R. Mishra A. Bhavani P.D. Singh S. Sharma H. Dwivedi M. Synthesis of some tetrazole and thiazolidine-4-one derivatives of schiff base by using ionic liquids as catalyst and evaluation of their antifungal and antibacterial activity. Eur. Chem. Bull. 2023 12 281 297
    [Google Scholar]
  132. Pathak R. Sharma H. Nogai L. A brief review on pathogenesis, transmission and management of monkeypox virus outbreaks. Bull. Environ. Pharmacol. Life Sci. 2023 12 4 244 256
    [Google Scholar]
  133. Sharma H Bhattacharya V Bhatt A Garg S Chaurasia G Akram W Sharma K Mandal S. “Optimization of formulation by box Behnken and in-vitro studies of emulsified gel containing zaltoprofen for the management of arthritis”. Eur. Chem. Bull. 2023 12 Special Issue 4 11734 11744
    [Google Scholar]
  134. Koli M. Nogai L. Bhandari M. Mishra R. Pathak R. Sharma H. Formulation and evaluation of berberine hydrochloride film coated tablet. J. Pharm. Negat. Res. 2023 14 2 3439 3449 10.47750/pnr.2023.14.02.403
    [Google Scholar]
  135. Dwivedi M. Jha K.K. Pandey S. Sachan A. Sharma H. Dwivedi S.K. Formulation and evaluation of herbal medicated chocolate in treatment of intestinal worms and related problems. IJFANS 2022 11 2 1426 1439
    [Google Scholar]
  136. Sharma H. Pathak R. Kumar N. Nogai L. Mishra R. Bhandari M. Koli M. Pandey P. Endocannabinoid system: Role in depression, recompense, and pain control. J. Sur. Fish. Sci. 2023 10 4S 2743 2751 10.17762/sfs.v10i4S.1655
    [Google Scholar]
  137. Sharma H Pathak R Saxena D Kumar N. “Emerging role of non-coding RNA’S: Human health and diseases”. GIS. 2022 9 7 2022 2050
    [Google Scholar]
  138. Sharma H. Rani T. Khan S. An insight into neuropathic pain: A systemic and up-to-date review. Int. J. Pharm. Sci. Res. 2023 14 2 607 621 10.13040/IJPSR.0975‑8232.14(2).607‑21
    [Google Scholar]
  139. Pandey P. Kumar N. Kaur T. Saini S. Sharma H. Antidiabetic activity of caesalpinia bonducella leavess of hydro alcoholic extracts in albino rats. YMER Digital 2022 21 7 840 846 10.37896/YMER21.07/67
    [Google Scholar]
  140. Pathak R. Sharma H. Kumar N. A brief review on anthocephalus cadamba. Acta Sci. Phar. 2022 3 5
    [Google Scholar]
  141. Sharma S. Dinda S.C.S.H. Matrix types drug delivery system for sustained release : A review. 2022 https://doi-ds.org/doilink/03.2022-65678198/ASIO-JDD/10.2016-21915953/2022/V6I1/920
    [Google Scholar]
  142. Sharma H. Pathak R. A review on prelimenary phytochemical screening of curcuma longa linn. J. Pharma. Herbal. Med. Res. 2021 7 2 24 27
    [Google Scholar]
  143. Pathak R. Sharma H. A review on medicinal uses of Cinnamomum verum (Cinnamon). J. Drug Deliv. Ther. 2021 11 6-S 161 166 10.22270/jddt.v11i6‑S.5145
    [Google Scholar]
  144. Sharma H. Pande M. Jha K.K. Hyperuricemia: A risk factor beyond gout. ASIO J. Phar. Herb. Med. Res. 2020 6 1 42 49
    [Google Scholar]
  145. Sharma H. Singh S. Jha K.K. Treatment and recommendations for homeless patients with hypertension, hyperlipidemia & heart failure-a review. ASIO J. Exp. Phar. Clin. Res. 2020 6 1 24 32
    [Google Scholar]
  146. Suryawanshi M. Kurtkoti S. Mulla T. Shah E. Sharma H. Bhatt H. Edible biopolymers for food applications. Green biopolymers for packaging applications. Internet Boca Raton CRC Press 2024 228 254 10.1201/9781003455356‑10
    [Google Scholar]
  147. Suryawanshi M. Mulla T. Suryawanshi I. Vinchurkar K. Kallawala U. Sharma H. Modified starch in food packaging. Green Biopolymers for Packaging Applications. Internet Boca Raton CRC Press 2024 255 271 10.1201/9781003455356‑11
    [Google Scholar]
  148. Sharma H. Kaushik M. Venishaa S. Pathak R. Farid A. Bhowmick M. Correlation and successive role of synbiotics to manage blood pressure. Synbiotics in Metabolic Disorders. Internet Boca Raton CRC Press 2024 103 120 10.1201/9781032702438‑7
    [Google Scholar]
  149. Ray P. Faseeh M.A. Adak D. Sharma H. Probiotics, prebiotics, and postbiotics on metabolic diseases targeting gut microbiota. Synbiotics in Metabolic Disorders. Internet Boca Raton CRC Press 2024 160 172 10.1201/9781032702438‑11
    [Google Scholar]
  150. Chandra P. Sharma H. Sachan N. The potential role of prebiotics, probiotics, and synbiotics in cancer prevention and therapy. Synbiotics in Metabolic Disorders. Internet Boca Raton CRC Press 2024 191 213 10.1201/9781032702438‑13
    [Google Scholar]
/content/journals/cgt/10.2174/0115665232356780250331181436
Loading
Next-Generation Whole-Exome Pattern: Advanced Methods and Clinical Significance
Bentham Science Publishers ; https://doi.org/10.2174/0115665232356780250331181436
/content/journals/cgt/10.2174/0115665232356780250331181436
/content/journals/cgt/10.2174/0115665232356780250331181436
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Diagnostic ; hereditary disorders ; next-generation sequencing ; variants detection ; whole-exome sequencing ; genomic-medicine ; targeted gene panels

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test